CDC approves Moderna, Pfizer-BioNTech Omicron booster shots for everyone 12 and older
Author
Blaire Bryant
Upcoming Events
Related News
Key Takeaways
On September 5, the Centers for Disease Control and Prevention (CDC) endorsed the Advisory Committee on Immunization Practices’ (ACIP) recommendation for updated COVID-19 boosters for everyone age 12 and up, following the Food and Drug Administration’s (FDA) approval of an emergency use authorization for the updated Pfizer-BioNTech and Moderna boosters on August 31. The boosters generate stronger immune protection against COVID-19 variants that are currently circulating widely in the U.S.
The updated emergency use authorizations permit the administration of a single booster at least two months after a primary or booster dose is given. The CDC Director, Dr. Rochelle Walensky, released a statement recommending eligibility for the Pfizer-BioNTech bivalent COVID-19 booster for people ages 12 and older and the Moderna COVID-19 booster for people ages 18 and older. The updated COVID-19 boosters add protection against the Omicron BA.4 and BA.5 variants, which currently make up nearly 90 percent of all cases of COVID-19 in the U.S. The CDC booster recommendation is for all individuals that have received at least a full primary vaccination series, which according to CDC guidance includes both a primary (2-dose) series and a one-dose booster.
The Biden administration has ordered 175 million doses of the new boosters. Pfizer plans to ship up to 15 million doses of its booster to the U.S. by September 9. Additionally, Pfizer plans to apply for an emergency use authorization for its booster to be used for children ages 5-11 in early October and is working to receive FDA approval for boosters for children under the age of 5.
The COVID-19 vaccines authorized for use in the U.S. continue to reduce the risk of severe disease, hospitalization and death, including against the Omicron variant and subvariants. As key providers of local public health services and frontline service providers for the medically vulnerable, counties have supported the administration of more than 610 million vaccinations in the United States to date and will continue to play an essential role in the administration of COVID-19 vaccines and boosters.
ADDITIONAL RESOURCES
Resource
The County Role in Vaccines
Related News
The Michelle Alyssa Go Act: Why Reforming the IMD Exclusion Matters for County Behavioral Health
Reintroduced in the U.S. House of Representatives in September 2025, the bipartisan Michelle Alyssa Go Act (H.R. 5462) aims to modernize the IMD exclusion and expand access to care.
CMS issues guidance on six-month Medicaid renewals
On March 6, the Centers for Medicare & Medicaid Services (CMS) released a letter to State Medicaid Directors with implementation guidance on six-month Medicaid renewals required under H.R. 1.
HHS Secretary Kennedy touts fixes for obesity, chronic illness, mental health issues
Counties can help improve health outcomes by prioritizing prevention over treatment, Robert F. Kennedy Jr., secretary of the U.S. Department of Health and Human Services told NACo Legislative Conference attendees.